Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis

British Journal of Cancer

Volumn 70, Issue 4, 1994, Pages 684-689

  Leenstra, S ^a   Bijlsma, E K ^a   Troost, D ^a   Oosting, J ^a   Westerveld, A ^a   Bosch, D A ^a   Hulsebos, T J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; AGING; ARTICLE; ASTROCYTOMA; CANCER GRADING; CHROMOSOME 10; CHROMOSOME 17P; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE LOSS; HETEROZYGOSITY; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; AGING; ALLELES; ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENE DELETION; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS;

EID: 0028106514     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.373     Document Type: Article

References (44)

1. AYOUBI, S., WALTER, P.H., AIK, S., SANKARAN, M. & ROBINSON, D. (1993). Audit in the management of gliomas. Br. J. Seurosurg., 7, 61–69.
2. BAKER, S.J., PREISINGER, AC, JESSUP, J.M., PARASKEVA, C. M., ARKOWITZ, S. & WILLSON, J.K. (1990). p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717–7722.
3. BIGNER, S.H., BURGER, PC, WONG, A.J., WERNER, M.H., HAMILTON, SR, MUHLBAIER, L.H., VOGELSTEIN, B & BIGNER, D.D (1988). Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J. Seuropathol. Exp. Seurol., 47, 191–205.
4. BURGER, P C & GREEN, S.B., (1987). Patient age. histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 59, 1617–1625.
5. BIJLSMA, E.K., LEENSTRA, S., WESTERVELD, A., BOSCH, D.A. & HULSEBOS, T.J.M. (1994). Amplification of the anonymous marker D17S67 in malignant astrocytomas. Genes Chrom. Cancer. 9, 148–152.
6. CHUNG, R.W., HALEY, J., KLEY, N., ANDERSON, K., LOUIS, D., MENON, A., HETTLICH, C., FREIMAN, R., HEDLEY-WHYTE, E.T., MARTUZA, R., JENKINS, R., YANEDELL, D. & SEIZINGER, B.R. (1991). TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chrom. Cancer. 3, 323–331.
7. COLLINS, V.P. & JAMES, C.D., (1993). Gene and chromosomal alterations associated with the development of human gliomas. FASEB J., 7, 926–930.
8. CURRAN Jr. W.J., SCOTT, C.B., HORTON, J., NELSON, J.S., WEINSTEIN, AS, NELSON, D.F., FISCHBACH, A.J., CHANG, C.H., ROTMAN, M., ASBELL, S.O., & POWLIS, W.D. (1992). Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J. Seurooncol., 12, 219–227.
9. DAUMAS-DUPORT, C., SCHEITHAUER, B., O FALLON, J. & KELLY, P. (1988). Grading of astrocytomas. Cancer. 62, 2152–2165.
10. EKSTRAND, A.J., JAMES, CD, CAVENEE, W.K., SELIGER, B., PETTERSSON, R.F. & COLLINS, V.P. (1991). Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res., 51, 2164–2172.
11. EL-AZOUZI, M., CHUNG, R.Y., FARMER, G.E., MARTUZA, R.L., BLACK, P.M., ROULEAU, G.A., HETTLICH, C., HEDLEY-WHYTE, E.T., ZERVAS, N.T., PANAGOPOULOS, K., NAKAMURA, Y., GUSELLA, J.F. & SEIZINGER, B.R. (1989). Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocvtomas. Proc. Satl Acad. Sci. L SA, 86, 7186–7190.
12. FEINBERG, A.P. & VOGELSTEIN, B.A. (1984). Addendum. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 137, 266–267.
13. FRANKEL, R.H., BAYONA, W., KOSLOW, M. & NEWCOMB, E.W. (1992). p53 mutations in human malignant gliomas: comparison of loss of heterozygositv with mutation frequency. Cancer Res., 52, 1427–1433.
14. FUJIMOTO, M., FULTS, D.W., THOMAS, G.A., NAKAMURA, Y., HEILBRUN, M.P., WHITE, R., STORY, J.L., NAYLOR, S.L., KAGAN-HALLET, K.S. & SHERIDAN, P.J. (1989). Loss of heterozygosity on chromosome 10 in human glioblastomas multiforme. Genomics. 4, 210–214.
15. FULTS, D., TIPPETS, R.H., THOMAS, G.A., NAKAMURA, Y. & WHITE, R. (1989). Loss of heterozy gosity for loci on chromosome 17p in human malignant astrocvtoma. Cancer Res., 49, 6572–6577.
16. FULTS, D., PEDONE, C.A., THOMAS, G.A. & WHITE, R. (1990). Allelotype of human malignant astrocytoma. Cancer Res., 50, 5784–5789.
17. FULTS, D., BROCKMEYER, D., TULLOUS, M.W., PEDONE, C.A. & CAWTTHON, R.M. (1992). p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52, 674–679.
18. FULTS, F. & PEDONE, C. (1993). Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Gene Chrom. Cancer. 7, 173–177.
19. HUMAN GENE MAPPING 11 (1991). Cvtogenet. Cell Genet., 58, 1–2200.
20. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. & HARRIS, C.C. (1991). p53 mutations in human cancers. Science. 253, 49–53.
21. HURTT, M.R., MOOSSY, J., DONOVAN-PELUSO, M. & LOCKER, J. (1992). Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J. Neuropathol. Exp. Neurol., 51, 84–90.
22. JAMES, CD., CARLBOM, E., DUMANSKJ, J.P., HANSEN, M., NORDENSKJOLD, M., COLLINS, V.P. & CAVENEE, W.K. (1988). Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48, 5546–5551.
23. JAMES, C D, CARLBOM, E., NORDENSKJOLD, M., COLLINS, V.P. & CAVENEE, W.K. (1989). Mitotic recombination of chromosome 17 in astrocytomas. Proc. Natl Acad Sci USA, 86, 2858–2862.
24. KARLBOM, E.A., JAMES, C.D., BOETHIUS, J., CAVENEE, W.K., COLLINS, V.P., NORDENSKJOLD, M. & LARSSON, C. (1993). Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum. Genet., 92, 169–174.
25. KERNOHAN, J.W. & SAYRE, G.P. (1952). Tumors of the Central Nervous System. Armed Forces Institute of Washington: Washington, DC.
26. LEENSTRA, S., TROOST, D., WESTERVELD, A., BOSCH, D.A., & HULSEBOS, T.J.M. (1992). Molecular characterization of areas with low grade tumor or satelhtosis in human malignant astrocytomas. Cancer Res., 52, 1568–1572.
27. MATLASHEWSKI, G.J., TUCK, S., PIM, D., LAMB, P., SCHNEIDER, J. & CRAWFORD, L.V. (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol., 7, 961–963.
28. MATSUNAMI, N., SMITH, B., BALLARD, L., LENSCH, M.W., ROBERTSON, M., ALBERTSEN, H., HANEMANN, C.O., MULLER, H.W., BIRD, T.D., WHITE, R. & CHANCE, P.F. (1992). Peripheral myelin protein-22 gene maps in the duplication in chromosome 17pl 1.2 associated with Charcot-Marie-Tooth 1A. Nature Genet., 1, 176–179.
29. NIGRO, J.M., BAKER, SJ., PREISINGER AC., JESSUP, J.M., HOSTETTER, R., CLEARY, K. & BIGNER, S.H. (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature. 342, 705–708.
30. NORTH, B., REILLY, P., BLUMBERGS, P., RODER D. & ESTERMAN, A. (1990). Malignant astrocytoma in South Australia: treatment and case survival. Med. J. Aust., 153, 250–254.
31. PENTAO, L., WISE, C.A., CHINAULT, A.C., PATEL, P.I., & LUPSKI, J.R., (1992). Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genet., 2, 292–300.
32. RANSOM, D.T., RUTLAND, S.R., MOERTEL, C.A., DAHL, RJ., O’FALLON, J.R., SCHEITHAUER, B.W., KIMMEL, D.W., KELLY, PJ, OLOPADE, O.I., DIAZ, M.O. & JENKINS, R.B. (1992). Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chrom. Cancer. 5, 357–374.
33. RASHEED, B.K.A., FULLER, G.N., FRIEDMAN, A.H., BIGNER, D.D. & BIGNER, S.H. (1992). Loss of heterozygosity for lOq loci in human gliomas. Genes Chrom. Cancer. 5, 75–82.
34. REVESZ, T., SCARAVILLI, F., COUTINHO, L., COCKBURN, H., SACARES, P. & THOMAS, D.G.T. (1993). Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain, 116, 781–793.
35. SALFORD, L.F., BRUN, A. & NIRFALK, S. (1988). Ten-year survival among patients with supra tentorial astrocytomas grade III and IV, J. Neurosurg., 69, 506–509.
36. SCANLON, P.W. & TAYLOR, W.F. (1979). Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery, 5, 301–308.
37. TROELSTRA, C., LANDSVATER, R.M., WIEGANT, J., VAN DER PLOEG, M., VIEL, G., BUYS, C.H.C.M. & HOEUMAKERS, J.H.J. (1992). Localization of the nucleotide excision repair gene ERCC6 to human chromosome lOql 1 -q21. Genomics. 12, 745–749.
38. VENTER, DJ, & THOMAS, D.G. (1991). Multiple sequential molecular abnormalities in the evolution of human gliomas. Br. J. Cancer. 63, 753–757.
39. VON DEIMLING, A., EIBL, R.H., OHGAKI, H., LOUIS, D.N., VON AMMON, K., PETERSEN, I., KLEIHUES, P., CHUNG, R.Y., WIESTLER O.D. & SEIZINGER B.R. (1992a). p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52, 2987–2990.
40. VON DEIMLING, A., LOUIS, D.N., VON AMMON, K., PETERSEN, I., HOELL, T., CHUNG, R.Y., MARTUZA, R.L., SCHOENFELD, D.A., Y AS ARGIL, M.G. & WIESTLER, O.D. (1992b). Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J. Neurosurg., 77, 295–301.
41. VON DEIMLING, A., VON AMMON, K., SCHOENFELD, D., WIESTLER, O.D., SEIZINGER, B.R & LOUIS, D.N. (1993). Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol, 3, 19–26.
42. WATANABE, K., NAGAI, M., WAKAI, S., ARAI, T & KAWASHIMA, K. (1990). Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathol., 80, 251–254.
43. WONG, A.J., BIGNER S.H., BIGNER D.D., KINZLER K.W., HAMILTON, S.R. & VOGELSTEIN, B. (1987). Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl Acad. Sci. USA, 84, 6899–6903.
44. WRIGHT, S.P. (1992). Adjusted p-values for simultaneous inference. Biometrics, 48, 1005–1013.